查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1756442

微小殘留疾病檢測市場（依產品、技術、應用、最終用戶、國家及地區）－2024 年至 2032 年產業分析、市場規模、市場佔有率及預測

Minimal Residual Disease Testing Market, By Product, By Technology, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 397 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年微小殘留疾病檢測市場規模價值 14.56 億美元，2024 年至 2032 年的複合年成長率為 12.5%。

微小殘留疾病檢測市場-市場動態

個人化醫療需求日益成長

個人化醫療需求的不斷成長，是包括癌症治療和診斷在內的各個醫療保健領域的重要驅動力。個人化醫療專注於根據基因、環境和生活方式因素，為個別患者量身定做治療方案，以提高療效並減少不良反應。這一趨勢加速了微小殘留疾病 (MRD) 檢測等技術的普及。透過識別復發風險高的患者，MRD 檢測有助於制定更有針對性的治療方案，從而改善療效。隨著個人化治療方案日益普及，MRD 檢測等先進診斷工具的市場預計將不斷擴大，為醫療保健專業人員提供更有效管理和治療疾病的更好選擇。這種向個人化醫療的轉變推動了相關診斷市場的成長。

微小殘留疾病檢測市場—關鍵洞察

根據我們的研究分析師，全球微小殘留疾病檢測市場預計在 2024 年至 2032 年期間以約 12.5% 的複合年成長率發展。

2024 年按產品細分，檢測試劑盒和試劑類別佔據了市場主導地位。

根據技術，聚合酶鍊式反應在 2024 年產生的收入最多。

按地區分類，2024年北美是收入最高的地區。

微小殘留疾病檢測市場-細分分析：

全球微小殘留疾病檢測市場分為五大類：產品、技術、應用、最終用戶和地區。

微小殘留疾病 (MRD) 檢測市場主要分為兩大類：檢測試劑盒和試劑以及儀器。檢測試劑盒和試劑對於執行 MRD 檢測至關重要，它們為樣本分析提供必要的組件，並確保在低水平下準確檢測微小殘留疾病。這些試劑盒因其成本效益高、易於使用且能夠提供精確的結果而需求旺盛。另一方面，流式細胞儀和 PCR 儀等儀器對於執行 MRD 檢測和分析樣本也至關重要。雖然這兩個部分對檢測過程都至關重要，但檢測試劑盒和試劑佔據了市場主導地位。它們價格實惠且適用於各種檢測環境，使其成為臨床診斷和研究的首選。個人化醫療的成長進一步支持了對這些產品日益成長的需求。

MRD 檢測市場按技術細分為聚合酶鍊式反應 (PCR)、新一代定序 (NGS)、流式細胞儀和其他技術。聚合酶鍊式反應 (PCR) 是一種廣泛應用的技術，因為它能夠擴增特定的 DNA 序列，從而能夠高靈敏度地檢測出微量殘留病灶。新一代定序 (NGS) 是一種更先進的技術，它提供深度定序功能，可以深入了解基因突變並幫助檢測微小病灶。流式細胞儀使用螢光標記抗體來識別和定量特定細胞類型，在識別血液樣本中的異常或殘留細胞方面發揮關鍵作用。雖然所有技術都具有顯著優勢，但聚合酶鍊式反應 (PCR) 憑藉其成熟的可靠性、廣泛的應用和經濟高效的性價比，在市場中佔據主導地位。由於其在檢測微小病灶方面具有精確度和可擴展性，它仍然是 MRD 檢測的首選方法，尤其是在臨床環境中。

微小殘留疾病檢測市場-地理洞察

從地理來看，微小殘留疾病檢測市場分佈於北美、亞太地區、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

在北美，美國在微小殘留疾病 (MRD) 檢測市場中佔據主導地位，這得益於其先進的醫療基礎設施、大量的研發活動以及尖端技術的高採用率。美國在個人化醫療和分子診斷領域處於領先地位，主要醫療機構和生技公司都在投資 MRD 檢測技術。加拿大緊隨其後，得益於其強而有力的醫療政策和完善的醫療體系。兩國對精準醫療和先進診斷工具的需求不斷成長，支撐著市場的強勁成長。

在歐洲，德國憑藉其強大的醫療保健體系、對生物技術的大量投資以及完善的研究機構，成為MRD檢測的關鍵市場。德國對精準醫療和疾病早期檢測的重視推動了MRD檢測的普及。英國是另一個佔據主導地位的國家，其醫療保健產業資金雄厚，對先進診斷技術的需求也很高。英國積極參與研究和臨床試驗，加上對微小殘留疾病的認知不斷提高，使其成為歐洲MRD檢測的關鍵市場。

微小殘留疾病檢測市場-競爭格局：

微小殘留疾病 (MRD) 檢測市場的競爭態勢由現有的醫療保健和診斷公司以及新興的創新企業共同塑造。像羅氏製藥 (F. Hoffmann-La Roche AG)、美國實驗室控股公司 (Laboratory Corporation of America Holdings) 和 Guardant Health Inc. 這樣的大型企業憑藉尖端的 MRD 檢測解決方案佔據主導地位，這些解決方案具有極高的準確性和靈敏度。這些公司在研發方面投入巨資，以增強其診斷技術並保持合規性。而像 Adaptive Biotechnologies 和 Archerdx 這樣的新進者則專注於新一代定序 (NGS) 和液體活體組織切片等創新方法，以改善檢測和監測。這種競爭促進了 MRD 檢測的持續進步，從而改善了患者的治療效果。

最新動態：

2025年4月，Guardant Health對其液體活體組織切片平台進行了重大升級，增強了其檢測微小殘留病灶 (MRD) 的能力，並提高了靈敏度。這項改進能夠更早發現癌症復發，因此能夠更及時、更有針對性地進行干預。此平台靈敏度的提升尤其有利於患者治療後監測，進而改善患者的整體預後。

2024年7月，羅氏完成了LumiraDx即時診斷技術的收購，旨在擴大基層醫療機構的診斷檢測覆蓋範圍。此次收購增強了羅氏提供去中心化檢測解決方案的能力，有助於在多樣化的醫療環境中更早發現和監測包括MRD在內的疾病。 LumiraDx技術的整合符合羅氏在全球範圍內拓展診斷服務覆蓋範圍的策略。

目錄

第1章：微小殘留疾病檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 微小殘留疾病檢測市場產品片段
    • 微小殘留疾病檢測市場（依技術）
    • 微小殘留疾病檢測市場片段（依應用）
    • 微小殘留疾病檢測市場片段（按最終用戶）
    • 微小殘留疾病檢測市場（按國家/地區）
    • 微小殘留疾病檢測市場（按地區）
  • 競爭洞察

第3章：微小殘留疾病檢測關鍵市場趨勢

  • 微小殘留疾病檢測市場促進因素
    • 市場促進因素的影響分析
  • 微小殘留疾病檢測市場限制
    • 市場限制的影響分析
  • 微小殘留疾病檢測市場機遇
  • 微小殘留疾病檢測市場未來趨勢

第4章：微小殘留疾病檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：微小殘留疾病檢測市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：微小殘留疾病檢測市場格局

  • 2023年微小殘留疾病檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：微小殘留疾病檢測市場－依產品

  • 概述
    • 按產品細分的市佔率分析
    • 檢測試劑盒和試劑
    • 儀器

第 8 章：微小殘留疾病檢測市場 - 按技術

  • 概述
    • 按技術細分的市場佔有率分析
    • 聚合酶鍊式反應
    • 下一代定序
    • 流式細胞儀
    • 其他技術

第9章：微小殘留疾病檢測市場—依應用

  • 概述
    • 按應用細分市場佔有率分析
    • 血液系統惡性腫瘤
      • 白血病
      • 骨髓性白血病
      • 淋巴球白血病
      • 其他白血病
      • 淋巴瘤
      • 非何杰金氏淋巴瘤
      • 霍奇金淋巴瘤
    • 實體腫瘤
    • 多發骨髓瘤
    • 其他應用

第 10 章：微小殘留疾病檢測市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和專科診所
    • 診斷實驗室
    • 學術及研究機構
    • 其他最終用戶

第 11 章：微小殘留疾病檢測市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美微小殘留疾病檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲微小殘留疾病檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區微小殘留疾病檢測主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（按產品）
    • 亞太市場規模及預測（按技術）
    • 亞太市場規模及預測（按應用）
    • 亞太市場規模及預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲微小殘留疾病檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲微小殘留疾病檢測主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：關鍵供應商分析-微小殘留疾病檢測產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • F. Hoffmann-La Roche AG
    • Laboratory Corporation of America Holdings
    • Guardant Health Inc.
    • Sysmex Corporation
    • Neogenomics Laboratories
    • Molecularmd
    • Adaptive Biotechnologies
    • Archerdx
    • Bio-Rad Laboratories Inc.
    • Natera, Inc.
    • Opko Health
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5342

REPORT HIGHLIGHT

Minimal Residual Disease Testing Market size was valued at USD 1,456 Million in 2024, expanding at a CAGR of 12.5% from 2024 to 2032.

Minimal Residual Disease (MRD) testing is a diagnostic tool used to detect the presence of residual cancerous cells that remain in a patient after treatment. These cells are often at extremely low levels and are undetectable through traditional imaging or biopsy methods. MRD testing is particularly important in hematologic cancers, such as leukemia and lymphoma, where it helps to identify patients at risk of relapse. By detecting minimal disease levels, MRD testing can guide treatment decisions, monitor disease progression, and help assess the effectiveness of ongoing therapies. It is essential for personalized patient care and improving outcomes.

Minimal Residual Disease Testing Market- Market Dynamics

Increasing Demand for Personalized Medicine

The growing demand for personalized medicine is a significant driver in various healthcare sectors, including cancer treatment and diagnostics. Personalized medicine focuses on tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors, enhancing the effectiveness and reducing adverse effects. This trend has accelerated the adoption of technologies like Minimal Residual Disease (MRD) testing. By identifying patients at high risk for relapse, MRD testing facilitates more targeted therapies, improving outcomes. As personalized treatment plans become increasingly popular, the market for advanced diagnostic tools, such as MRD testing, is expected to expand, offering healthcare professionals better options to manage and treat diseases effectively. This shift towards individualized care supports growth in related diagnostic markets.

Minimal Residual Disease Testing Market- Key Insights

According to our research analyst, the global Minimal Residual Disease Testing Market is expected to develop at a CAGR of approximately 12.5% between 2024-2032.

Segmented by Product in 2024, the Assay Kits & Reagents category dominated the market.

Based on Technology, the Polymerase Chain Reaction generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Minimal Residual Disease Testing Market- Segmentation Analysis:

The global Minimal Residual Disease Testing Market is divided into five categories: Product, Technology, Application, End User and Region.

The Minimal Residual Disease (MRD) testing market is primarily divided into two segments: Assay Kits & Reagents and Instruments. Assay kits and reagents are essential for performing MRD tests, providing the necessary components for sample analysis, and ensuring accurate detection of minimal residual disease at low levels. These kits are in high demand due to their cost-effectiveness, ease of use, and ability to deliver precise results. On the other hand, instruments such as flow cytometers and PCR machines are crucial for executing MRD tests and analyzing the samples. While both segments are critical to the testing process, Assay Kits & Reagents dominate the market. Their affordability and adaptability to various testing environments make them a preferred choice in clinical diagnostics and research. The growth in personalized medicine further supports the increasing demand for these products.

The MRD testing market is segmented by technology into Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Flow Cytometry, and Other Technologies. Polymerase Chain Reaction (PCR) is a widely used technology due to its ability to amplify specific DNA sequences, enabling the detection of low levels of residual disease with high sensitivity. Next-Generation Sequencing (NGS) is a more advanced technology that offers deep sequencing capabilities, providing detailed insights into genetic mutations and aiding in detecting minimal disease. Flow Cytometry uses fluorescently labeled antibodies to identify and quantify specific cell types, playing a pivotal role in identifying abnormal or residual cells in blood samples. While all technologies offer significant advantages, Polymerase Chain Reaction (PCR) dominates the market due to its established reliability, widespread adoption, and cost-effectiveness. It remains the most preferred method for MRD testing, especially in clinical settings, due to its precision and scalability in detecting minimal disease levels.

Minimal Residual Disease Testing Market- Geographical Insights

Geographically, the Minimal Residual Disease Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

In North America, the United States is the dominant player in the Minimal Residual Disease (MRD) testing market, driven by advanced healthcare infrastructure, significant research and development activities, and a high adoption rate of cutting-edge technologies. The U.S. leads in personalized medicine and molecular diagnostics, with major healthcare institutions and biotech companies investing in MRD testing technologies. Canada follows closely, benefiting from strong healthcare policies and a well-developed healthcare system. The increasing demand for precision medicine and advanced diagnostic tools in both countries supports robust market growth.

In Europe, Germany stands out as a key market for MRD testing, owing to its strong healthcare system, significant investment in biotechnology, and well-established research institutions. Germany's emphasis on precision medicine and early detection of diseases fuels the adoption of MRD testing. The United Kingdom is another dominant player, with a well-funded healthcare sector and high demand for advanced diagnostics. The UK's active participation in research and clinical trials, along with increasing awareness of minimal residual disease, makes it a critical market for MRD testing within Europe.

Minimal Residual Disease Testing Market- Competitive Landscape:

The competitive dynamics of the Minimal Residual Disease (MRD) Testing market are shaped by both established healthcare and diagnostic players, as well as emerging innovators. Major players like F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, and Guardant Health Inc. dominate with cutting-edge MRD testing solutions, offering high accuracy and sensitivity. These firms invest heavily in R&D to enhance their diagnostic technologies and maintain regulatory compliance. New entrants, such as Adaptive Biotechnologies and Archerdx, focus on innovative methods like next-generation sequencing (NGS) and liquid biopsy, which improve detection and monitoring. This competition fosters continual advancements in MRD testing, enhancing patient outcomes.

Recent Developments:

In April 2025, Guardant Health introduced a significant upgrade to its liquid biopsy platform, enhancing its ability to detect minimal residual disease (MRD) with greater sensitivity. This advancement allows for earlier detection of cancer recurrence, enabling more timely and targeted interventions. The platform's increased sensitivity is particularly beneficial in monitoring patients post-treatment, improving overall patient outcomes.

In July 2024, Roche completed the acquisition of LumiraDx's point-of-care technology, aiming to expand access to diagnostic testing in primary care settings. This acquisition enhances Roche's capabilities in providing decentralized testing solutions, facilitating earlier detection and monitoring of diseases, including MRD, in diverse healthcare environments. The integration of LumiraDx's technology aligns with Roche's strategy to broaden the reach of its diagnostic services globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche AG
  • Laboratory Corporation of America Holdings
  • Guardant Health Inc.
  • Sysmex Corporation
  • Neogenomics Laboratories
  • Molecularmd
  • Adaptive Biotechnologies
  • Archerdx
  • Bio-Rad Laboratories Inc.
  • Natera, Inc.
  • Opko Health x
  • Others

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Assay Kits & Reagents
  • Instruments

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Polymerase Chain Reaction
  • Next-Generation Sequencing
  • Flow Cytometry
  • Other Technologies

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Hematological Malignancies
  • Leukemia
  • Myeloid Leukemia
  • Lymphocytic Leukemia
  • Other Leukemias
  • Lymphoma
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Solid Tumors
  • Multiple Myeloma
  • Other Applications

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Specialty Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Other End Users

GLOBAL MINIMAL RESIDUAL DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Minimal Residual Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Minimal Residual Disease Testing Market Snippet by Product
    • 2.1.2. Minimal Residual Disease Testing Market Snippet by Technology
    • 2.1.3. Minimal Residual Disease Testing Market Snippet by Application
    • 2.1.4. Minimal Residual Disease Testing Market Snippet by End User
    • 2.1.5. Minimal Residual Disease Testing Market Snippet by Country
    • 2.1.6. Minimal Residual Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Minimal Residual Disease Testing Key Market Trends

  • 3.1. Minimal Residual Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Minimal Residual Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Minimal Residual Disease Testing Market Opportunities
  • 3.4. Minimal Residual Disease Testing Market Future Trends

4. Minimal Residual Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Minimal Residual Disease Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Minimal Residual Disease Testing Market Landscape

  • 6.1. Minimal Residual Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Minimal Residual Disease Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Assay Kits & Reagents
    • 7.1.3. Instruments

8. Minimal Residual Disease Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 8.1.2. Polymerase Chain Reaction
    • 8.1.3. Next-Generation Sequencing
    • 8.1.4. Flow Cytometry
    • 8.1.5. Other Technologies

9. Minimal Residual Disease Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Hematological Malignancies
      • 9.1.2.1. Leukemia
      • 9.1.2.1.1. Myeloid Leukemia
      • 9.1.2.1.2. Lymphocytic Leukemia
      • 9.1.2.1.3. Other Leukemias
      • 9.1.2.2. Lymphoma
      • 9.1.2.2.1. Non-Hodgkin Lymphoma
      • 9.1.2.2.2. Hodgkin Lymphoma
    • 9.1.3. Solid Tumors
    • 9.1.4. Multiple Myeloma
    • 9.1.5. Other Applications

10. Minimal Residual Disease Testing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Specialty Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Other End Users

11. Minimal Residual Disease Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Minimal Residual Disease Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Minimal Residual Disease Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Minimal Residual Disease Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Minimal Residual Disease Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Minimal Residual Disease Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Minimal Residual Disease Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. F. Hoffmann-La Roche AG
    • 12.2.2. Laboratory Corporation of America Holdings
    • 12.2.3. Guardant Health Inc.
    • 12.2.4. Sysmex Corporation
    • 12.2.5. Neogenomics Laboratories
    • 12.2.6. Molecularmd
    • 12.2.7. Adaptive Biotechnologies
    • 12.2.8. Archerdx
    • 12.2.9. Bio-Rad Laboratories Inc.
    • 12.2.10. Natera, Inc.
    • 12.2.11. Opko Health
    • 12.2.12. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us